Determining the Change of Hormonal and Biochemical Parameters in the Thalassemia Major Patients Over ۳ Years

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 148

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_INJPM-11-2_005

تاریخ نمایه سازی: 9 اسفند 1401

Abstract:

Background: Endocrinopathies are common complications in Thalassemia Major (TM) patients. They are important as secular trends of complications in childhood as a critical period for growth and development. The present study, then, aimed to investigate these complications in children and young adults.Methods: ۳۴ TM patients, with the mean age of ۱۹ ± ۶ y/o, entered this study. Female to male ratio was ۲۱/۱۳. Their medical history was obtained by review of medical records. Data about FBS, AST, ALT, TG, cholesterol, and ferritin, TSH, LH and FSH was collected. Due to the lack of normality of some continuous variables, an appropriate transformation method was implemented to convert them to normal distribution. Repeated measure ANOVA was used to assess change of outcomes across time. Correlations between different parameters were also calculated.Results: After ۳ years, only FBS changed significantly in comparison to phase ۱ and ۲ results (P-value=۰.۰۲۸).  Ferritin in the first phase significantly correlated with ALT (P-value = ۰.۰۲۱), in the second phase with AST (P-value=۰.۰۲۹) and ALT (P-value=۰.۰۰۲) and in the third phase with FSH, LH and TG (P-value=۰.۰۴۷, ۰.۰۲۰, ۰,۰۲۷, respectively). In the first phase AST correlated with TG and cholesterol (P-value=۰.۰۱۵, ۰.۰۰۱, respectively) and ALT with cholesterol (P-value <۰.۰۰۱). ALT correlated with TG in the second phase (P-value=۰.۰۴۰). ALT and AST correlated with cholesterol in the third phase (P-value=۰.۰۰۲, ۰.۰۰۷, respectively).Conclusion: Hormonal parameters do not show significant change during a ۳ years period in TM patients.

Keywords:

Thalasemia , , , , , Bichemistry , , , , , Hormone , , , , , cohort

Authors

Mohammad-Reza Mohajeri-Tehrani

Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Mobina Ostadi

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Hadis Gerami

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Bagher Larijani

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Zohreh Hamidi

۱- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Mohajeri-Tehrani MR, Darvishian N, Arab F, Salemkar S, Mohseni F, ...
  • Hamidi Z. What We Learn from Bone Complications in Congenital ...
  • Belhoul KM, Bakir ML, Saned M-S, Kadhim A, Musallam KM, ...
  • Mahmoud RA, Khodary A, Farhan MSJIJoP. Detection of endocrine disorders ...
  • Jensen C, Tuck S, Agnew J, Koneru S, Morris R, ...
  • Poggi M, Sorrentino F, Pugliese P, Smacchia MP, Daniele C, ...
  • Cairo H, Holl RW, Debatin K-M, Kohne EJEjop. Insulin sensitivity ...
  • Dhouib NG, Khaled MB, Ouederni M, Besbes H, Kouki R, ...
  • Mohajeri-Tehrani M-R, Hamidieh AA, Naghash A, Behfar M, Alimoghaddam K, ...
  • Hamidieh AA, Mohseni F, Behfar M, Hamidi Z, Alimoghaddam K, ...
  • Hamidi z, mohajeri-tehrani m, alemzadeh a, abbaszadeh-marzbali f, naseri-sina s, ...
  • Shahriari M, Sadjadian NJE-EMHJ, ۹, ۵۵-۶۰. Prevalence of endocrine complications ...
  • De Sanctis V, Soliman AT, Canatan D, Yassin MA, Daar ...
  • De Sanctis V, Daar S, Soliman AT, Tzoulis P, Karimi ...
  • De Sanctis V, Soliman AT, Yassin MA, Di Maio S, ...
  • Altincik A, Akin MJJopho. Prevalence of endocrinopathies in Turkish children ...
  • Sharma R, Seth A, Chandra J, Gohain S, Kapoor S, ...
  • Kell DB, Pretorius EJM. Serum ferritin is an important inflammatory ...
  • Fan N, Peng L, Xia Z, Zhang L, Song Z, ...
  • Arguello G, Balboa E, Arrese M, Zanlungo SJBeBA-MBoD. Recent insights ...
  • نمایش کامل مراجع